Intervacc is trading at €0.05, down 22.07%; no clear catalyst has been identified for the September 28, 2026 move.
- The latest surfaced company announcement, dated September 15, concerned a presentation at the Swiss Nordic Bio Conference on October 1; it did not report a major new event.
- U.S. equities also fell on September 28 amid rising oil prices and Treasury yields, but this does not establish a cause for Intervacc’s decline.